Expected and Unexpected Imaging Findings after 90Y Transarterial Radioembolization for Liver Tumors

JC Spina, I Hume, A Pelaez, O Peralta, M Quadrelli… - Radiographics, 2019 - pubs.rsna.org
Transarterial radioembolization (TARE), also called radioembolization or selective internal
radiation therapy, is an interventional radiology technique used to treat primary liver tumors …

[HTML][HTML] Current state of the art imaging approaches for colorectal liver metastasis

B Hazhirkarzar, P Khoshpouri… - … surgery and nutrition, 2020 - ncbi.nlm.nih.gov
One of the most common cancers worldwide, colorectal cancer (CRC) has been associated
with significant morbidity and mortality and therefore represents an enormous burden to the …

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after 90Y radioembolization of colorectal liver metastases: a …

W Shady, S Kishore, S Gavane, RK Do… - European journal of …, 2016 - Elsevier
Purpose To compare the performance of 4 metrics of metabolic response on FDG-PET/CT
against RECIST 1.0 for determining response and predicting overall survival (OS) following …

Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic …

CT Sofocleous, AR Garcia, N Pandit-Taskar… - Clinical Colorectal …, 2014 - Elsevier
Introduction This prospective study assessed the safety and outcomes of selective internal
radiation therapy (SIRT) using yttrium-90 (90 Y) resin microspheres as a salvage therapy for …

Surrogate imaging biomarkers of response of colorectal liver metastases after salvage radioembolization using 90Y-loaded resin microspheres

W Shady, VS Sotirchos, RK Do… - American Journal of …, 2016 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of the present study is to evaluate Response Evaluation Criteria
in Solid Tumors (RECIST) version 1.1, tumor attenuation criteria, Choi criteria, and European …

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer

L Puleo, L Agate, I Bargellini, G Boni… - European thyroid …, 2022 - etj.bioscientifica.com
Objectives Liver metastases occur in 45% of patients with advanced metastatic medullary
thyroid cancer (MTC). Transarterial radioembolization (TARE) has been proposed to treat …

Imaging tumor response following liver-directed intra-arterial therapy

Y Guo, V Yaghmai, R Salem, RJ Lewandowski… - Abdominal …, 2013 - Springer
Liver-directed intra-arterial therapies are palliative treatment options for patients with
unresectable liver cancer; their use has also resulted in patients being downstaged leading …

Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy

R Golfieri, C Mosconi, E Giampalma, A Cappelli… - La radiologia …, 2015 - Springer
Purpose The target lesion response (according to the Choi criteria), safety and survival
following selective or superselective transarterial radioembolisation using yttrium-90-resin …

The Role of 18F‐FDG‐PET and PET/CT in Patients with Colorectal Liver Metastases Undergoing Selective Internal Radiation Therapy with Yttrium‐90: A First …

S Annunziata, G Treglia, C Caldarella… - The Scientific World …, 2014 - Wiley Online Library
Purpose. To provide a first evidence‐based review of the literature on the role of fluorine‐18‐
fluorodeoxyglucose positron emission tomography and positron emission …

靶向时代肿瘤疗效评价标准的探索

王琳, 王馨 - 中国肿瘤临床, 2015 - cjco.cn
肿瘤分子靶向药物具有与化疗药物不同的作用机理. 目前对肿瘤的疗效评价标准主要是针对化疗
药物疗效的评价, 从最早的WHO 标准发展到RECIST 和RECIST1. 1 标准, 尽管在细节和标准化 …